The association between blood lipids and cognitive impairment in type 2 diabetes mellitus


Here are the The association between blood lipids and cognitive impairment in type 2 diabetes mellitus journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

American heart association blood pressure log, the association between a and b, the association between sleep duration, the association cherish, association between smoking and cancer, association between diet and health, the association band, association of blood banks.

The association between blood lipids and cognitive impairment in type 2 diabetes mellitus

Objective: The study was performed to explore the association between blood lipids and cognitive impairment in patients with type 2 diabetes mellitus (T2DM).

Methods: This study included 336 patients with T2DM. Relevant clinical data including total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), apolipoprotein A1, apolipoprotein B were collected, and the Mini-Mental State Examination (MMSE) score and Montreal Cognitive Assessment (MoCA) score were used to assess the cognitive function in patients with T2DM.

Results: Serum apolipoprotein A1 levels were significantly increased in T2DM patients with cognitive impairment compared with T2DM patients without cognitive impairment (p = 0.017). Serum apolipoprotein A1 levels were significantly negatively correlated with MoCA score (r = − 0.143, p = 0.009) and MMSE score (r = − 0.132, p = 0.016) in patien ts with T2DM. In multivariable-adjusted regression model, serum apolipoprotein A1 was independently associated with cognitive impairment in patients with T2DM (OR = 5.201, p = 0.024).

Conclusion: Serum apolipoprotein A1 is associated with cognitive impairment in patients with T2DM, but not TC, TG, HDL-C, LDL-C, and apolipoprotein B, indicating that increased serum apolipoprotein A1 may be a risk factor of cognitive impairment in patients with T2DM. © 2023, The Author(s).

Authors : Ma L.; Yuan Y.-X.; Cheng F.-J.; Liu Y.; Wei Q.; Peng Y.-F.; Wang Y.

Source : BioMed Central Ltd

Article Information

Year 2024
Type Article
DOI 10.1186/s40001-023-01574-w
ISSN 09492321
Volume 29

You can download the article here


If You have any problem, contact us here


Support Us:

Download Now Buy me a coffee Request Paper Here